Trial details
Development of new primary prostate cancer cell lines
To find out more about this trial and your cancer treatment options, please speak with your doctor.
Trial short name: PCa Cell Growth
Official title: Development of new primary prostate cancer cell lines
Principal Investigator:
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Other
Intervention: Other: Registry with collection of samples (blood and biopsy)
Registration #: N/A
Trial description:
The purpose of this study is to look at cancer cells in blood and tumour samples from patients with prostate cancer. Patients diagnosed with prostate cancer who meet a certain criteria may be able to participate. Patients will give blood and tumour samples prior to treatment. The goal is to find biological differences in patients to tell us more about their cancer and how they will react to treatment. No treatment will be provided to patients as part of this study.
Inclusion Criteria: • All individuals must be male and have a pathological diagnosis of prostate cancer • Prostate cancer patient being scheduled for definitive radiotherapy treatment • Signed consent form Exclusion Criteria: • Did not sign consent form
